BioNTech Hosts Second AI Day with InstaDeep

Ticker: BNTX · Form: 6-K · Filed: Oct 1, 2025 · CIK: 1776985

Biontech Se 6-K Filing Summary
FieldDetail
CompanyBiontech Se (BNTX)
Form Type6-K
Filed DateOct 1, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: AI, biotechnology, innovation, subsidiary

TL;DR

BioNTech's AI Day 2.0 is here, showcasing AI-driven drug development with InstaDeep.

AI Summary

On October 1, 2025, BioNTech SE, in collaboration with its AI subsidiary InstaDeep Ltd., held its second AI Day. This event showcased advancements and future directions in the application of artificial intelligence within BioNTech's operations and research.

Why It Matters

This event highlights BioNTech's strategic focus on integrating AI into its drug discovery and development processes, potentially accelerating innovation and improving therapeutic outcomes.

Risk Assessment

Risk Level: low — The filing is an informational report about an event and does not contain material financial changes or new risks.

Key Players & Entities

  • BioNTech SE (company) — Registrant and presenter
  • InstaDeep Ltd. (company) — AI subsidiary and collaborator
  • October 1, 2025 (date) — Date of the AI Day event

FAQ

What was the purpose of BioNTech's second AI Day?

The purpose was to showcase advancements and future directions in the application of artificial intelligence within BioNTech's operations and research, in collaboration with its AI company InstaDeep Ltd.

When did BioNTech host its second AI Day?

BioNTech hosted its second AI Day on October 1, 2025.

Which subsidiary was involved in BioNTech's second AI Day?

BioNTech's AI company, InstaDeep Ltd., was involved in the second AI Day.

What type of company is InstaDeep Ltd. in relation to BioNTech?

InstaDeep Ltd. is BioNTech's artificial intelligence (AI) company.

What form was filed with the SEC regarding this event?

A Form 6-K was filed with the SEC, reporting on the month of October 2025 and including information about the AI Day presentation.

Filing Stats: 256 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2025-10-01 09:05:32

Filing Documents

From the Filing

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a16 OR 15d16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF OCTOBER 2025 COMMISSION FILE NUMBER 001-39081 BioNTech SE (Translation of registrant's name into English) An der Goldgrube 12 D-55131 Mainz Germany +49 6131-9084-0 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20F or Form 40F Form 20F Form 40F Indicate by check mark if the registrant is submitting the Form 6K in paper as permitted by Regulation ST Rule 101(b)(1) Indicate by check mark if the registrant is submitting the Form 6K in paper as permitted by Regulation ST Rule 101(b)(7) DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K On October 1, 2025, BioNTech SE ("BioNTech"), alongside its artificial intelligence ("AI") company InstaDeep Ltd., hosted its second AI Day, an edition of BioNTech's "Innovation Series", providing an overview of BioNTech's AI strategy and capabilities and the application of AI in BioNTech's pipeline and internal processes. The presentation is attached hereto as Exhibit 99.1. SIGNATURE Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BioNTech SE By s Ramon Zapata-Gomez By s Dr. Sierk Poetting Name Ramon Zapata-Gomez Name Dr. Sierk Poetting Title Chief Financial Officer Title Chief Operating Officer Date October 1, 2025 EXHIBIT INDEX Exhibit Description of Exhibit 99.1 Presentation

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.